Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenqu Xiaoshi Oral Liquid for Microbiome in Pediatric Functional Dyspepsia
NCT05515887Phase 4Completed
- Sponsor
- Ruijin Hospital
- Start
- Nov 2022
- Primary completion
- Dec 2024
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of shen qu xiao shi oral liquid in functional dyspepsia (FD), sponsored by Ruijin Hospital. Started Nov 2022; status: completed.
02
Drugs
shen qu xiao shi oral liquid
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT05515887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05515887.